ANA MOYA: Open Payments
NPI 1568690550 · FALLS CHURCH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,513 in 108 payments from 27 companies in 2025. Trend: 2023 $1,239 · 2024 $2,068 · 2025 $2,513
Food & beverage: $2,413Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $322 |
| Amgen Inc. | 16 | $246 |
| PFIZER INC. | 15 | $227 |
| Novo Nordisk Inc | 7 | $189 |
| ABBVIE INC. | 13 | $171 |
| Sumitomo Pharma America, Inc. | 5 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $152 |
| Abbott Laboratories | 1 | $151 |
| Astellas Pharma US Inc | 3 | $139 |
| Kowa Pharmaceuticals America, Inc. | 1 | $137 |
Products named: PREVNAR 20, OTEZLA, GEMTESA, CAPLYTA, ESPRIT, ZORYVE, BREZTRI, FARXIGA.
Industry payments across VA — which companies pay providers there.
